C-3 Amido-Indole cannabinoid receptor modulators

Bioorganic & Medicinal Chemistry Letters
2002.0

Abstract

C-3 Amido-indoles were found to selectively bind to the CB2 receptor. SAR studies led to optimized compounds with excellent in vivo potency against LPS induced TNF-alpha release in murine models of cytokine production.

Knowledge Graph

Similar Paper

C-3 Amido-Indole cannabinoid receptor modulators
Bioorganic & Medicinal Chemistry Letters 2002.0
Indol-3-yl-tetramethylcyclopropyl Ketones: Effects of Indole Ring Substitution on CB<sub>2</sub> Cannabinoid Receptor Activity
Journal of Medicinal Chemistry 2008.0
Indol-3-ylcycloalkyl Ketones: Effects of N1 Substituted Indole Side Chain Variations on CB<sub>2</sub> Cannabinoid Receptor Activity
Journal of Medicinal Chemistry 2010.0
New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure–activity relationships, physicochemical properties and biological activity
European Journal of Medicinal Chemistry 2011.0
Rational Design and Synthesis of an Orally Active Indolopyridone as a Novel Conformationally Constrained Cannabinoid Ligand Possessing Antiinflammatory Properties
Journal of Medicinal Chemistry 2003.0
Alkyl indole-based cannabinoid type 2 receptor tools: Exploration of linker and fluorophore attachment
European Journal of Medicinal Chemistry 2018.0
Sulfamoyl benzamides as novel CB2 cannabinoid receptor ligands
Bioorganic &amp; Medicinal Chemistry Letters 2008.0
New class of potent ligands for the human peripheral cannabinoid receptor
Bioorganic &amp; Medicinal Chemistry Letters 1996.0
Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists
Bioorganic &amp; Medicinal Chemistry Letters 2009.0